Middle East & Africa Parenteral Nutrition Market

The Middle East & Africa parenteral nutrition market was valued at US$ 208.88 million in 2022 and is expected to reach US$ 288.90 million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030.

Innovation in Formulations of Nutrition Products Bolster Middle East & Africa Parenteral Nutrition Market

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.

Middle East & Africa Parenteral Nutrition Market Overview

According to a mid-2020 report from the General Authority for Statistics, ~25,000 babies are born prematurely in Saudi Arabia yearly. The premature babies are placed in incubators for 30-60 days, which can cost government hospitals or insurance companies ~US$ 16,000 (SAR 60,000) for individual treatment and specialized care. If babies are required to be kept in incubation for longer periods, it can cost ~US$ 26,667 (SAR 100,000). In such a scenario, nutritional support is crucial to attain a similar growth rate compared to babies of the same age, and it can be provided through enteral or parenteral ways. Most immature preterm babies depend on parenteral nutrition, especially for babies born with low birth weight (<1,500g). Such babies are not offered enteral feeding due to the severity of medical problems associated with prematurity (such as underdeveloped major organs, infections, and feeding intolerance). The Ministry of Health (MoH) in the country operates 287 hospitals. According to the data published by the MoH, 236 hospitals currently provide home healthcare, of which some either incorporate either home enteral nutrition (HEN) or home parenteral nutrition (HPN), or both services. Therefore, the demand for parenteral nutrition is anticipated to grow rapidly in Saudi Arabia due to the rising number of premature births and increasing government efforts to support and spread awareness among the population regarding parenteral nutrients.

Middle East & Africa  Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa  Segmentation

The Middle East & Africa parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Middle East & Africa is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Middle East & Africa is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Middle East & Africa is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Middle East & Africa .

Middle East & Africa Parenteral Nutrition Market Strategic Insights

Middle East & Africa Parenteral Nutrition Market Segmentation Analysis

Middle East & Africa Parenteral Nutrition Market Report Highlights

Middle East & Africa Parenteral Nutrition Report Scope

Middle East & Africa Parenteral Nutrition Market Country and Regional Insights